Efemoral Medical is a 2022 Rosenman Innovator and developer of the Efemoral Vascular Scaffold System (EVSS) for the treatment of peripheral […]
FDA Grants Breakthrough Device Status to the 2022 Rosenman Innovator, Efemoral Medical

Efemoral Medical is a 2022 Rosenman Innovator and developer of the Efemoral Vascular Scaffold System (EVSS) for the treatment of peripheral […]
Bloomlife, a 2019 Rosenman Innovator and award winning maternal health company, has gained FDA clearance for their first maternal and […]
2023 ADAPT Finalist, Isaac Health, successfully completed an oversubscribed $5.7 million Seed round to redefine the future of brain healthcare […]
The FDA has granted clearance to Neuralace Medical’s Axon Therapy to treat chronic pain related to nerve damage caused by […]
Nest Collaborative, a 2023 Rosenman Innovator and premier virtual lactation support platform, has secured $6M in funding, bringing its total […]
Enspectra Health, a 2018 Rosenman Innovator, announced FDA clearance for the VIO System, which has tremendous potential for evaluating skin […]
Encellin has secured $9.9M in financing to advance its groundbreaking Encapsulated Cell Replacement Therapy (EnCRT) for Type 1 Diabetes (T1D). […]
2020 Rosenman Innovator, Nanochon, received an investment for their regenerative cartilage technology. The investment will enable Nanochon to continue development […]
Savage Medical, a 2023 Rosenman Innovator, raised $3M for its minimally invasive solution that aims to eliminate surgeries and complications […]
Surgical technology company Centese announced the successful closing of its $15M Series B round led by UCSF Rosenman Institute partner […]